LOADING
Comparing Microsoft Corporation (MSFT) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | PFE |
|---|---|---|
| Price | $495.40 | $26.79 |
| Change Today | -0.30% | -0.04% |
| Market Cap | $3.68T | $152.7B |
| P/E Ratio | 27.7 | 35.3 |
| Forward P/E | 25.7 | 9.2 |
| PEG Ratio | 1.65 | 2.62 |
| EPS | $17.88 | $0.76 |
| Revenue Growth (YoY) | 17.7% | 2.6% |
| Profit Margin | 40.3% | 6.8% |
| Return on Equity | 34.0% | 5.0% |
| Dividend Yield | 0.73% | 6.42% |
| Beta | 1.10 | 0.28 |
| 52-Week High | $550.24 | $27.80 |
| 52-Week Low | $349.20 | $22.03 |
| Volume | 16.2M | 23.2M |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.